πŸ‡ΊπŸ‡Έ FDA
Patent

US 11643656

Antisense therapies for treating cancer

granted A61KA61K31/7088A61K45/06

Quick answer

US patent 11643656 (Antisense therapies for treating cancer) held by The United States Government represented by the Department of Veterans Affairs expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States Government represented by the Department of Veterans Affairs
Grant date
Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/7088, A61K45/06, A61K47/6807, A61K9/51